FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...

Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML

By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...

New targeted combination in people with relapsed acute myeloid leukemia shows promise

New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational ...
Morningstar

Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment

WASHINGTON, Jan. 14, 2026 /PRNewswire/ -- Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment in a new sub-study of its Beat ...

Blood Cancer United Data at 2026 ASCO and EHA Highlight Beat AML Progress, Patient Experience Insights and Access Barriers

Blood Cancer United announced today that new data across its portfolio of funded research will be presented in more than 50 ...